文献速递鼻科

鼻息肉内类固醇注射治疗鼻息肉病:系统评价与网状Meta分析

Intrapolyp Steroid Injection for Nasal Polyposis: A Systematic Review and Network Meta-Analysis.
PubMed 文献 · Laryngoscope · 2024-12-21

本系统评价与网状Meta分析纳入8项临床试验共579例慢性鼻窦炎伴鼻息肉患者,评估鼻息肉内类固醇注射与口服类固醇、鼻类固醇冲洗、鼻类固醇喷雾及对照组的疗效与安全性。结果显示注射组视觉障碍和出血事件率低,疗效与口服类固醇相当,对鼻喷雾、冲洗和对照组显示一定优势。

要点

  • 鼻息肉内类固醇注射的视觉障碍事件率为0.64%,出血事件率为0.61%。
  • 鼻息肉内类固醇注射与口服类固醇疗效相当,差异无统计学意义。
  • 鼻息肉内类固醇注射对鼻喷雾、鼻冲洗和对照组显示一定优势。

核心结论

  • 鼻息肉内类固醇注射作为慢性鼻窦炎伴鼻息肉的一种可行治疗选择,具有有利的安全性和有效性特征。
  • 注射与口服类固醇疗效相当,并较鼻喷雾和鼻冲洗等其他治疗显示一定优势。

研究设计与样本

  • 系统评价与网状Meta分析,纳入随机和非随机临床试验,检索PubMed、Scopus、Web of Science、Embase和CENTRAL数据库。
  • 共分析8项临床试验,涉及579例患者,使用RoB-2和ROBINS-I工具评估偏倚风险。

主要发现

  • 视觉障碍事件率为0.64%(95% CI [0.00%, 2.23%]),出血事件率为0.61%(95% CI [0.00%, 2.25%])。
  • 鼻息肉内类固醇注射与口服类固醇相比,差异无统计学意义。
  • 鼻息肉内类固醇注射对鼻喷雾、鼻冲洗和对照组显示一定优势。

关键数值与推荐

  • 安全性数据以事件率(%)合并,有效性数据以均数差(MD)或标准化均数差(SMD)合并。
  • 结局包括视觉障碍和出血发生率,以及内镜、影像学和患者报告三个领域的鼻息肉改善评估。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要更大样本量和标准化方案进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To conduct a systematic review and network meta-analysis to evaluate the safety and efficacy of intrapolyp steroid injection compared with oral steroids, nasal steroid wash, nasal steroid spray, and a control group in patients with chronic rhinosinusitis with nasal polyps (CRSwNP). DATA SOURCES: PubMed, Scopus, Web of Science, Embase, and CENTRAL. REVIEW METHODS: Both randomized and non-randomized clinical trials were included. For risk of bias assessment, we used the RoB-2 and ROBINS-I tools. Our outcomes focused on safety and efficacy, including rates of visual disturbance and bleeding, as well as improvements in nasal polyps evaluated through three domains: endoscopic, radiologic, and patient-reported assessments. Safety data were pooled as events (%), while efficacy data were pooled as mean difference (MD) or standardized mean difference (SMD). RESULTS: Eight clinical trials involving 579 patients were analyzed. The pooled analyses showed low event rates for visual disturbances (event rate = 0.64%, 95% CI [0.00%, 2.23%]) and bleeding (event rate = 0.61%, 95% CI [0.00%, 2.25%]). Additionally, intrapolyp steroid injections were found to be comparable with oral steroids, with no statistically significant differences. Moreover, intrapolyp steroid injections demonstrated some superiority over nasal sprays, nasal washes, and the control group. CONCLUSION: This network meta-analysis confirms that intrapolyp steroid injections have a favorable safety and efficacy profile as a viable management option for CRSwNP. The injections showed comparable efficacy with oral steroids and demonstrated certain advantages over other treatments, such as nasal sprays and washes. Further research with larger sample sizes and standardized protocols are needed. Laryngoscope, 135:1872-1883, 2025.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Albazee E, Abu-Zaid A, Althaidy M, et al. Intrapolyp Steroid Injection for Nasal Polyposis: A Systematic Review and Network Meta-Analysis. Laryngoscope. 2024. PMID: 39707800. doi:10.1002/lary.31969

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。